Literature DB >> 9502438

Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.

R O Darouiche1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502438     DOI: 10.1086/516315

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  15 in total

1.  The role of Candida albicans AP-1 protein against host derived ROS in in vivo models of infection.

Authors:  Charu Jain; Kelly Pastor; Arely Y Gonzalez; Michael C Lorenz; Reeta P Rao
Journal:  Virulence       Date:  2013-01-01       Impact factor: 5.882

2.  Potentiation of azole antifungals by 2-adamantanamine.

Authors:  Michael D Lafleur; Lingmei Sun; Ida Lister; John Keating; Andre Nantel; Lisa Long; Mahmoud Ghannoum; Jeffrey North; Richard E Lee; Ken Coleman; Thomas Dahl; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

Review 3.  Invasive oesophageal candidiasis: current and developing treatment options.

Authors:  Jose A Vazquez
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.

Authors:  Mohammad H Al-Shayyab; Osama A Abu-Hammad; Mahmoud K Al-Omiri; Najla S Dar-Odeh
Journal:  Int Dent J       Date:  2015-07-07       Impact factor: 2.607

5.  Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.

Authors:  Jose A Vazquez
Journal:  HIV AIDS (Auckl)       Date:  2010-04-28

6.  Molecular identification of Candida species isolated from gastro-oesophageal candidiasis in Tehran, Iran.

Authors:  Rasoul Mohammadi; Saeed Abdi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  Species identification of Candida isolates obtained from oral lesions of HIV infected patients.

Authors:  V P Baradkar; S Kumar
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

8.  Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.

Authors:  Omar J M Hamza; Mecky I N Matee; Mainen J Moshi; Elison N M Simon; Ferdinand Mugusi; Frans H M Mikx; Wim H van Palenstein Helderman; Antonius J M M Rijs; André J A M van der Ven; Paul E Verweij
Journal:  BMC Microbiol       Date:  2008-08-12       Impact factor: 3.605

9.  Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.

Authors:  Jose A Vazquez
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

10.  Organotypical tissue cultures from adult murine colon as an in vitro model of intestinal mucosa.

Authors:  Petra M Bareiss; Marco Metzger; Kai Sohn; Steffen Rupp; Julia S Frick; Ingo B Autenrieth; Florian Lang; Heinz Schwarz; Thomas Skutella; Lothar Just
Journal:  Histochem Cell Biol       Date:  2008-03-05       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.